CAS 560130-42-9
:Vancomycin, N3′′-[2-(decylamino)ethyl]-29-[[(phosphonomethyl)amino]methyl]-, hydrochloride (1:1)
Description:
Vancomycin, N3′′-[2-(decylamino)ethyl]-29-[[(phosphonomethyl)amino]methyl]-, hydrochloride (1:1) is a synthetic derivative of the glycopeptide antibiotic vancomycin, which is primarily used to treat serious bacterial infections, particularly those caused by Gram-positive bacteria. This compound features a complex structure that includes a decylamino side chain and a phosphonomethyl group, which may enhance its antibacterial activity or alter its pharmacokinetic properties. The hydrochloride form indicates that it is a salt, which can improve solubility and stability in aqueous solutions. The presence of the phosphonomethyl group suggests potential for increased interaction with bacterial cell wall synthesis, a common mechanism of action for antibiotics. As with many antibiotics, the efficacy and safety profile of this compound would be evaluated through clinical studies, focusing on its spectrum of activity, resistance patterns, and potential side effects. Overall, this compound represents a modification of a well-established antibiotic, aiming to improve therapeutic outcomes against resistant bacterial strains.
Formula:C80H106Cl2N11O27P·HCl
InChI:InChI=1S/C80H106Cl2N11O27P.ClH/c1-7-8-9-10-11-12-13-14-21-85-22-23-87-80(5)32-57(115-37(4)71(80)103)119-70-68(102)67(101)55(34-94)118-79(70)120-69-53-28-41-29-54(69)117-52-20-17-40(27-46(52)82)65(99)63-77(109)91-61(78(110)111)43-30-50(96)44(33-86-35-121(112,113)114)66(100)58(43)42-25-38(15-18-49(42)95)59(74(106)93-63)90-75(107)60(41)89-73(105)48(31-56(83)97)88-76(108)62(92-72(104)47(84-6)24-36(2)3)64(98)39-16-19-51(116-53)45(81)26-39;/h15-20,25-30,36-37,47-48,55,57,59-65,67-68,70-71,79,84-87,94-96,98-103H,7-14,21-24,31-35H2,1-6H3,(H2,83,97)(H,88,108)(H,89,105)(H,90,107)(H,91,109)(H,92,104)(H,93,106)(H,110,111)(H2,112,113,114);1H/t37-,47+,48-,55+,57-,59+,60+,61-,62+,63-,64+,65+,67+,68-,70+,71+,79-,80-;/m0./s1
InChI key:InChIKey=GSSIWSIRBWAZHG-ACOPVEIWSA-N
SMILES:O(C=1C2=CC3=CC1OC=4C(Cl)=CC(=CC4)[C@@H](O)[C@@H](NC([C@@H](CC(C)C)NC)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@]3(C(=O)N[C@@]5(C=6C=C(C=7C([C@@H](C(O)=O)NC(=O)[C@]([C@H](O)C=8C=C(Cl)C(O2)=CC8)(NC5=O)[H])=CC(O)=C(CNCP(=O)(O)O)C7O)C(O)=CC6)[H])[H])[C@H]9[C@H](O[C@H]%10C[C@@](NCCNCCCCCCCCCC)(C)[C@H](O)[C@H](C)O%10)[C@@H](O)[C@H](O)[C@@H](CO)O9.Cl
Synonyms:- (3S,6R,7R,22R,23S,26S,36R,38aR)-3-(2-Amino-2-oxoethyl)-10,19-dichloro-44-((2-O-(3-((2-(decylamino)ethyl)amino)-3-C-methyl-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)-beta-D-glucopyranosyl)oxy)-7,22,28,30,32-pentahydroxy-6-(((2R)-4-methyl-2-(methylamino)pentanoyl)amino)-2,5,24,38,39-pentaoxo-29-(((phosphonomethyl)amino)methyl)-2,3,4,5,6,7,23,24,25,26,36,37,38,38a-tetradecahydro-8,11:18,21-dietheno-23,36-(iminomethano)-22H-13,16:31,35-dimetheno-1H,13H-(1,6,9)oxadiazacyclohexadecino(4,5-m)(10,2,16)benzoxadiazacyclotetracosine-26-carboxylic acid monohydrochloride
- Td 6424
- Unii-0701472Zg0
- Vancomycin, N3'-(2-(decylamino)ethyl)-29-(((phosphonomethyl)amino)methyl)-, monohydrochloride
- Vancomycin, N<sup>3′′</sup>-[2-(decylamino)ethyl]-29-[[(phosphonomethyl)amino]methyl]-, hydrochloride (1:1)
- Vancomycin, N<sup>3′′</sup>-[2-(decylamino)ethyl]-29-[[(phosphonomethyl)amino]methyl]-, monohydrochloride
- Vibativ
- Vancomycin, N3′′-[2-(decylamino)ethyl]-29-[[(phosphonomethyl)amino]methyl]-, hydrochloride (1:1)
- Telavancin hydrochloride
- Telavancin HCl
- PubChem ID: 9812715
- TelavancinHydrochlorid
- N3''-[2-(Decylamino)ethyl]-29-[[(phosphonomethyl)amino]methyl]vancomycin hydrochloride
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 2 products.
Telavancin HCl
CAS:<p>Telavancin HCl is a lipoglycopeptide antibiotic with action on bacterial cell wall synthesis and membrane integrity and is used for treating complicated skin infections and hospital-acquired pneumonia caused by gram-positive bacteria.</p>Formula:C80H106Cl2N11O27P·HClPurity:(%) Min. 92%Color and Shape:White PowderMolecular weight:1,792.1 g/mol

